ValuPanel Reagents are composed of pre-designed probes and primers that are intended to resolve the genetic signatures to of different pathogen strains. They are for Research Use Only (RUO), not for use in diagnostic procedures.
Charité 2019-nCoV BHQ ValuPanel Reagents
Charité 2019-nCoV BHQ™ ValuPanel™ Reagents are now part of the ValuPanel line of detection reagents. ValuPanel Reagents are composed of probes and primers that resolve genetic signatures of different pathogen strains. These signatures target the SARS-CoV-2 virus that causes COVID-19. For Research Use Only. Not for use in diagnostic procedures.
Key benefits
Fast delivery: Product ships in 5 to 7 business days, additional 2-3 business days for EMEA and APAC orders
Gold standard quencher: From the trusted inventor and original source of Black Hole Quencher™ (BHQ™) technology referenced in 7 of 8 WHO protocols
Quality manufacture: All probes are HPLC purified. Oligos are manufactured and shipped from a facility entirely separate from positive control production.Quality manufacture: All probes are HPLC purified. Oligos are manufactured and shipped from a facility entirely separate from positive control production.
Charité 2019-nCoV BBQ-650 ValuPanel Reagents
Charité 2019-nCoV BBQ-650 ValuPanel™ Reagents are now part of the ValuPanel line of detection reagents. ValuPanel Reagents are composed of probes and primers that resolve genetic signatures of different pathogen strains. These signatures target the SARS-CoV-2 virus that causes COVID-19. For Research Use Only. Not for use in diagnostic procedures.
Key benefits
Fast delivery: Product in stock ships same or next business day
Original source: Berry & Associates, Inventor of BlackBerry™ (BBQ-650™) technology referenced in Charité protocol, is now part of the Biosearch Technologies brand
Quality manufacture: All probes are HPLC purified. Oligos are manufactured and shipped from a facility entirely separate from positive control production.
US CDC 2019-nCoV ValuPanel Reagents
US CDC 2019-nCoV BHQ™ ValuPanel™ Reagents are now part of the ValuPanel line of detection reagents. ValuPanel Reagents are composed of probes and primers that resolve genetic signatures of different pathogen strains. These signatures target the SARS-CoV-2 virus that causes COVID-19. For Research Use Only. Not for use in diagnostic procedures.
Key benefits
Fast delivery: Product in stock ships same or next business day
Gold standard quencher: From the trusted inventor and original source of Black Hole Quencher™ (BHQ™) technology referenced in 7 of 8 WHO protocols
Quality manufacture: All probes and primers are HPLC purified and are manufactured and shipped from a facility entirely separate from positive control production.
Charité 2019-nCoV BHQ ValuPanel Reagents
| Item | Sequence |
| Charite RdRP_SARSr Pan Sarbeco FAM-BHQ Probe | FAM-CCAGGTGGWACRTCATCMGGTGATGC-BHQ1 |
| Charite RdRP_SARSr 2019-nCoV FAM-BHQ Probe | FAM-CAGGTGGAACCTCATCAGGAGATGC-BHQ1 |
| Charite RdRP_SARSr Forward Primer | GTGARATGGTCATGTGTGGCGG |
| Charite RdRP_SARSr Reverse Primer | CARATGTTAAASACACTATTAGCATA |
| Charite E_Sarbeco FAM-BHQ Probe | FAM-ACACTAGCCATCCTTACTGCGCTTCG-BHQ1 |
| Charite E_Sarbeco Forward Primer | ACAGGTACGTTAATAGTTAATAGCGT |
| Charite E_Sarbeco Reverse Primer | ATATTGCAGCAGTACGCACACA |
Product info
This panel consists of FAM-BHQ probes for use in real-time RT PCR to discriminate SARS-CoV-2 viral strains. This ValuPanel contains probes and primers based on genetic signatures for the following:
RdRP – Confirmatory assay
Pan Sarbeco-Probe to detect 2019-nCoV, SARS-CoV and bat-SARS-related CoVs
Probe specific for 2019-nCoV, will not detect SARS-CoV
E Sarbeco – First line screening assay
Oligonucleotide sequences were designed by German Center for Infection Research (DZIF) at Charité. All probes are labeled with FAM and BHQ dyes, and are HPLC purified.
Charité 2019-nCoV BBQ-650 ValuPanel Reagents
| Item | Sequence |
| Charite RdRP_SARSr Pan Sarbeco FAM-BBQ-650 | FAM-CCAGGTGGWACRTCATCMGGTGATGC-BBQ650 |
| Charite RdRP_SARSr 2019-nCoV FAM-BBQ-650 Probe | FAM-CAGGTGGAACCTCATCAGGAGATGC-BBQ650 |
| Charite RdRP_SARSr Forward Primer | GTGARATGGTCATGTGTGGCGG |
| Charite RdRP_SARSr Reverse Primer | CARATGTTAAASACACTATTAGCATA |
| Charite E_Sarbeco FAM-BBQ-650Probe | FAM-ACACTAGCCATCCTTACTGCGCTTCG-BBQ650 |
| Charite E_Sarbeco Forward Primer | ACAGGTACGTTAATAGTTAATAGCGT |
| Charite E_Sarbeco Reverse Primer | ATATTGCAGCAGTACGCACACA |
Product info
This panel consists of FAM-BBQ-650 probes for use in real-time RT PCR to discriminate SARS-CoV-2 viral strains. This ValuPanel contains probes and primers based on genetic signatures for the following:
RdRP- Confirmatory assay
Pan Sarbeco-Probe to detect 2019-nCoV, SARS-CoV and bat-SARS-related CoVs
Probe specific for 2019-nCoV, will not detect SARS-CoV
E Sarbeco – First line screening assay
Oligonucleotide sequences were designed by German Center for Infection Research (DZIF) at Charité. All probes are labeled with FAM and BlackBerry (BBQ-650) dyes, and are HPLC purified. Berry & Associates, the inventor of BBQ-650 technology, is now part of the Biosearch Technologies brand.
| Item | Sequence |
| 2019-nCoV_N1 Probe | FAM-CCAGGTGGWACRTCATCMGGTGATGC-BBQ650 |
| 2019-nCoV_N1 Forward Primer | GAC CCC AAA ATC AGC GAA AT |
| 2019-nCoV_N1 Reverse Primer | TCT GGT TAC TGC CAG TTG AAT CTG |
| 2019-nCoV_N2 Probe | FAM-ACA ATT TGC CCC CAG CGC TTC AG-BHQ1 |
| 2019-nCoV_N2 Forward Primer | TTA CAA ACA TTG GCC GCA AA |
| 2019-nCoV_N2 Reverse Primer | GCG CGA CAT TCC GAA GAA |
| 2019-nCoV_N3 Probe | FAM-AYC ACA TTG GCA CCC GCA ATC CTG-BHQ1 |
| 2019-nCoV_N3 Forward Primer | GGG AGC CTT GAA TAC ACC AAA A |
| 2019-nCoV_N3 Reverse Primer | TGT AGC ACG ATT GCA GCA TTG |
| Human RNase P Extraction Control Probe | FAM-TTC TGA CCT GAA GGC TCT GCG CG-BHQ1 |
| Human RNase P Extraction Control Forward Primer | AGA TTT GGA CCT GCG AGC G |
| Human RNase P Extraction Control Reverse Primer | GAG CGG CTG TCT CCA CAA GT |
Product info
This panel consists of FAM-BHQ probes for use in real-time RT PCR to discriminate SARS-CoV-2 viral strains. This ValuPanel contains probes and primers comprising the following genetic signatures:
N
RNase P
Oligonucleotide sequences were designed by US Centers for Disease Control and Prevention. All probes are labeled with FAM and BHQ dyes, and are HPLC purified.
For more information, click on more info.